Dr. V. Wee Yong is a Professor at the University of Calgary, Canada, and the Canada Research Chair in Neuroimmunology. He co-directs the Multiple Sclerosis (MS) NeuroTeam of the Hotchkiss Brain Institute at the University of Calgary, providing the basic science leadership, and he directs the provincial Alberta MS Network. Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects are guided by MS, spinal cord injury and brain tumors. Dr. Yong has published 280 peer-reviewed manuscripts and his research has been translated into Phase III clinical trials in MS and spinal cord injury. His work has been cited over 17,000 times by other authors (web of science; h-index of 74). Dr. Yong is a past chair of the Medical Advisory Committee of the MS Society of Canada; this and other volunteer activities resulted in him receiving the Queen’s Golden Jubilee Year Medallion. Dr. Yong is on the editorial board of 7 international journals. He has been the President of the International Society of Neuroimmunology (2014-2016). Dr. Yong is an elected fellow of both the Canadian Academy of Health Sciences and the Royal Society of Canada, which represent top honors for those working in the medical and academic sciences, respectively. Dr. Yong is the 2017 Allyn Taylor International Prize in Medicine winner.
Neuroimmunology; Neuroprotection; CNS regeneration; MS; Spinal cord injury and Brain tumors
Some publications in the past 4 years:
1. Lau L, Cua R, Keough MB, Haylock-Jacob S, Yong VW, Pathophysiology of the brain extracellular matrix: A new target for remyelination, Nature Rev Neuroscience 14:722-729, 2013
2. Stephenson E, Nathoo N, Mahjoub Y, Dunn JF, Yong VW, Iron in Multiple Sclerosis: Roles in neurodegeneration and repair, Nature Rev Neurol 10:459-468, 2014
3. Keough MB, Rogers JA, Zhang P, Jensen SK, Robertson E, Chen T, Lau LW, Rawji KS, Plemel JR, Koch M, Ling CC, Yong VW, An inhibitor of chondroitin sulfate proteoglycan synthesis promotes CNS remyelination, Nature Communications 7:11312, 1-12, 2016
4. Jensen SK, Yong VW, Activity-dependent and experience-driven myelination provide new directions for the management of multiple sclerosis, Trends Neurosci 39:356-365, 2016
5. Clemente-Casares X, Blanco J, Ambalavalan P, Singha S, Yamanouchi J, Fandos C, Tsai S, Wang J, Agrawal S, Keough M, Yong VW, James E, Moore A, Yang Y, Stratmann T, Serra P, Santamaria P, Expanding antigen-specific regulatory networks to treat autoimmunity, Nature b530:434-440, 2016
6. Mishra MK, Yong VW, Myeloid cells: targets of medications in multiple sclerosis, Nature Rev Neurol 12:539-551, 2016
7. Metz LM, Li DKB, Traboulsee AL, Duquette P, Eliasziw M, Cerchiaro G, Greenfield J, Riddehough A, Yeung M, Kremenchutzky M, Vorobeychik G, Freedman MS, Bhan V, Blevins G, Marriott JJ, Grand'Maison F, Lee L, Thibault M, Hill MD, Yong VW for the Minocycline in MS Study Team, Trial of minocycline in clinically isolated syndrome of multiple sclerosis, New Engl J Med 376:2122-2133, 2017
8. Roger JA, Mishra MK, Hahn J, Greene C, Yates R, Metz L, Yong VW, Gestational BPA exposure lowers the threshold for autoimmunity in a model of multiple sclerosis, Proc Natl Acad Sci (USA) 114:4999-5004, 2017
9. Plemel JR, Liu WQ, Yong VW, Remyelination therapies: a new direction and challenge in multiple sclerosis, Nature Rev Drug Discovery, in press
Dr. Zhao is currently the Chairman of Department of Neurology in Xijing Hospital and the Vice President of Xijing Brain Hospital of the Fourth Military Medical University. He graduated from the Fourth Military Medical University in 1983, and continued his study of neuroinfection and cerebrospinal fluid cytology in Ghent University School of Medicine in 1992. From 1998 to 2002, he engaged in the research of cerebrovascular disease and neuroprotective drugs in Kingston General Hospital of Queen's University in Canada.
Dementia; Dizzy; Headache; Cerebrovascular Disease and Parkinson's Disease
Dr. Kyritsis received his MD in 1978 and DSc degree in 1988 from the Medical School of the National and Kapodistrian University of Athens Greece. Subsequently, he had basic research training at the National Institutes of Health, USA, from 1981 to 1986 and residency in Neurology at the University of Wisconsin University Hospital, Madison, Wisconsin, USA. Subsequently he did a clinical fellowship in Neuro-oncology at the Department of Neuro-Oncology at the University of Texas M. D. Anderson Cancer Center in Houston, Texas, and then served as Assistant and Associate Professor at the same department from 1992 to 1999. In 1999, he moved to the Department of Neurology at the University of Ioannina as Professor and Chairman of Neurology.
Neurogenic inflammation; Papilledema; Radiculopathy; Cerebrospinal fluid and Radiotherapy
Use of various functional, morphologic brain imaging techniques (MRI, fMRI, SPECT, PET) in the diagnosis and evaluation of progression of neurodegenerative disorders, i.e. Parkinson’s disease in combination with various simple instrumental tools; Performance of neuropharmacological trials with putative neuroprotective or neuroregnerative compounds in neurodegenerative disease at least partially in close cooperation with the pharmaceutical industry; Investigations of neuroophthalmologic changes in neurodegnerative disorders and the impact of dopaminergic compounds on visual function; Studies on the pathogenesis of Parkinson’s disease, dystonia, Huntington’s disease, vascular brain disease and dementia with search for genetic, metabolic and environmental biomarkers and risk factors for neurodegenerative diseases; Performance of epidemiologic, pharmacokinetic and pharmacologic trials on the efficacy of antiparkinsonian agents; Research on neuropsychological changes in neurodegenerative diseases; Development and use of instrumental procedures and various reaction time paradigms for the evaluation of drug response in Parkinson’s disease; Research on levodopa induced vascular risk factors in neurodegenerative diseases with specific evaluation of genetic polymorphisms of drug metabolizing enzymes; Evaluation of the clinical efficacy of intrathecally administered steroid preparation in the treatment of progressive multiple sclerosis with predominant spinal symptoms; Studies on fine motor skills and control in Parkinson‘s disease and related movement disorders
Dr. Dale Ding is a neurosurgeon in Charlottesville, Virginia and is affiliated with University of Virginia Medical Center. He received his medical degree from Duke University School of Medicine and has been in practice between 6-10 years. He is one of 14 doctors at University of Virginia Medical Center who specialize in Neurological Surgery.
Cerebral artery aneurysm; Acute ischemic stroke; Aneurysmal subarachnoid hemorrhage; Cerebral vasospasm and delayed cerebral ischemia
Internationally known for his work on Alzheimer’s disease, he is a Professor of Pharmacology, Microbiology and Immunology at Temple University, Lewis Katz School of Medicine. He has authored over 235 peer-reviewed articles and 22 chapters in thematic books. He has received many awards for his research accomplishments including the Biomedicine Investigator Award for Excellence in Scientific Research, Irvine H. Page Award for Medical Research, Neurosciences Education and Research Award, and The Zenith Award from the Alzheimer’s Association.
Oxidative neurobiology;Alzheimer’s disease ;Parkinson’sdisease;Frontotemporal dementia;Neurodegeneration
1. European Bristol-Myer-Squibb Post Doctoral Fellowship.
2. Italian Research Council Fellowship.
3. Investigator Award for Excellence in Scientific Research.
4. American Federation for Aging Research.
5. Irvine H. Page Research Award.
6. Neurosciences Education and Research Foundation Award.
7. Zenith Fellow of the Alzheimer’s Association.
8. Dorothy Dillon Eweson Lectureship.
He has published a total of 235 peer-reviewed articles.
Neuropsychiatry of Alzheimer's disease and Mild Cognitive Impairment Neuropsychiatry of Parkinson's disease;Neuropsychiatry of stroke; Cognitive deficits and associated brain structural abnormalities of schizophrenia; Mechanisms of brain aging and subclinical neuropsychiatry phenomenology in healthy people
He graduated in Medicine at Sao Paulo University, PhD in Neuropathology at University of Sao Paulo, ex-Fellowship in Skull Base surgery in Nordstadt Krankenhaus Hannover, Germany; Post Doc Fellow in Pituitary Center, Stanford University, California USA; Professor of Post Graduation in Surgery, at Federal University of Rio Grande do Sul, Brazil, Professor of Neurology at Catholic University of Sao Paulo, Brazil.
Brain aneurysms; Neuroncology; Skull base surgery; Stroke; Pituitary tumours; Microsurgical brain anatom
Dr. Ajami Experienced immunologist and molecular biologist with expertise in neuroinflammation, signaling and cancer biology. Highly knowledgeable of microglia and its biology in neurological diseases as evidenced by two first-author-papers in Nature Neuroscience journal cited and highly regarded over 1200 times. She Innovative immunologist with demonstrated scientific expertise in cutting-edge technology such as mass cytometry (CyToF), confocal and fluorescence microscopy, live cell imaging, flow cytometry, and in vivo rodent techniques. Deep knowledge and understanding of pathology in various neurological disorders such as Multiple Sclerosis, Huntington disease, Amyotrophic Lateral Sclerosis (ALS) and spinal cord injury. 18+ years experience in cultivating novel ideas, independent experimental planning and design, execution, evaluation, and presentation of data.
Neuroinflammation; Multiple sclerosis and Microglia
Dr. Alexiou is a Neurosurgeon at the University Hospital of Ioannina, Greece since 2016. He graduated from the same university in 2004. He undertook his neurosurgical training at “Agia Sofia’’ Children’s Hospital in Athens and at the University Hospital of Ioannina. After finishing his residency he received the EANS Spine Fellowship award and worked as a Clinical Fellow in the Department of Neurosurgery in Leeds Teaching Hospital, UK. He then served as a Fellow at the Department of Pediatric Neurosurgery in Boston Children's Hospital, Harvard Medical School after receiving the AANS International Travelling Fellowship. Dr. Alexiou started his preliminary Gamma Knife training at La Timone in Marseille, France. He has a Master degree in Biotechnology and Public Health. His PhD was on the differential diagnosis of glioma recurrence from radiation necrosis using SPECT and MRI and was funded by the Horizon 2020 program of the European Commission. Dr. Alexiou also worked as a postdoctoral research fellow at MD Anderson in Texas, and is currently working on basic research at the Neurosurgical Research Institute in Ioannina, Greece. His primary research interests are on the role of advanced imaging and radiotherapy techniques to improve the outcomes of glioma patients, on the role of flow cytometry for defining glioma margins and on the discovery and validation of novel chemotherapeutic agents for glioma treatment.
Clinical neurology and Neurosurgery
2001-2002 Resident in Neurosurgery, Kyoto University Hospital, Kyoto, Japan
2002-2004 Resident in Neurosurgery, Shiga Medical Center for Adults, Shiga, Japan
2004-2005 Staff Doctor in Neurosurgery, Maizuru Municipal Hospital, Kyoto, Japan
2009-2012 Research Fellowship for Young Scientists, Dept. Pharmacology, Kyoto University Graduate School of Medicine, Kyoto, Japan
2012-2017 Associate Professor, Innovation Center for Immunoregulation Technologies and Drugs, Kyoto University Graduate School of Medicine, Kyoto, Japan
2017-present Laboratory Chief, Dept. Molecular Pharmacology, Research Institute, National Cerebral and Cardiovascular Center, Osaka Japan
Vascular biology; Molecular biology; Pharmacology; Neurosurgery and Clarification of the molecular mechanism underlying the pathogenesis of intracranial aneurysm
Dr. Peggy Bosch received her MA-degree in Clinical Psychology (2002) from the Radboud University Nijmegen (Nijmegen, the Netherlands) and her PhD-degree in Psychology (2015) also from the Radboud University Nijmegen. She currently works as a postdoc at the Radboud University Nijmegen and as a clinical psychologist at the LVR-Klinik Bedburg-Hau (Kleve, Germany). Peggy is Head of the psychiatric research institute of the LVR-Klinik Bedburg-Hau (Kleve, Germany), conducting mainly research on schizophrenia, depression, and sleep disorders.
Schizophrenia, Depression, Sleep disorders, Trauma, fMRI, TMS
1. The development of a human (un)conscious brain information processing theory in which physics and neuroscience can be unified. [see also the Nature website: http://www.nature.com/nature/report/index.html?comment=68881&doi=10.1038/538036a]
2. Dr. Bosch is one of the leading Discussants of the possibilities and risks of brain stimulation. [see also Science: Science. 2014 Dec 12;346(6215):1307. doi: 10.1126/science.346.6215.1307-a
Staley A. Brod is a Professor of Neurology at the Medical College of Wisconsin. He graduated from Williams College with a degree in Philosophy in 1972 and obtained his Doctor of Medicine degree from the Medical College of Ohio in 1981. He completed residencies in Internal Medicine and Neurology at the Medical College of Ohio and the Yale-New Haven Medical Center at Yale University Medical School respectively and is board certified in both Internal Medicine and Neurology. He was an Associate Physician in Neurology at Brigham and Women's Hospital at the Harvard Medical School from 1987-1991, an Assistant Professor of Neurology in Division of Neuroimmunology, UT Southwestern Medical School in Dallas from 1991-93 and subsequently a Professor at the McGovern School of Medicine in Houston from 1993-2014. He is currently Director, Division of MS/Neuro-Immunology at the Medical College of Wisconsin. Dr. Brod has published over 100 abstracts and papers on the use of ingested type I interferons in humans and animal models of autoimmune disease. He was an award winner from the National Multiple Sclerosis Society to study the mechanism underlying the passive transfer of resistance to EAE from donors ingesting IFN-alpha, is an investigator of a grant investigating the basic mechanisms of multiple sclerosis funded by the Clayton Foundation, and was awarded an NIH grant to evaluate the biologic effects of oral interferon alpha in relapsing-remitting multiple sclerosis.
Dr. Bi-Tao Bu is a professor of Neurology Department, Tongji Hospital, Huazhong University of Science and Technology (HUST) in China. He had been educated at Hunan Medical College and Tongji Medical College of HUST respectively. He also had been trained at University of Washington for 2 years and at University of California at Davies for 1 year. He has been devoted to the clinical and basic studies on myasthenia gravis, inflammatory myopathies and neuromyelitis optica spectrum disorder. His study has been sponsored by Natural Science Foundation of China and Sino-German Joint Education Foundation. He is the member of Chinese Medical Society, Chinese Immunology Society, and American Society for Neurosciences.
Neurodegeneration and developmental disease; Neuroimmunology; Peripheral neurology and myopathy; The treatment of osteoarticular diseases by botox; Arthroscopy technique; Artificial joint replacement and muscle weakness; Muscle atrophy; Numbness nerve muscle and Nerve immunity myopathy
Dr. Hugh Chan received his PhD from Imperial College London in 2010. He is currently a postdoctoral fellow at the Neurosciences Department of Lerner Research Institute of Cleveland Clinic. His current research focuses on the rehabilitation and repair in experimental stroke and traumatic brain injury models.
Alzheimer’s disease; Parkinson’s disease; Stroke; Traumatic brain injury
Dr. Hugh Chan has rewarded the inaugural Best Abstract Awards in 2015; He has rewarded 2nd position of Young Scientists Presentation (Imperial College London) in 2008; He has rewarded 3rd position of Young Scientists Presentation (Imperial College London) in 2007; During 2005-2008, he has rewarded Dorothy Hodgkin Postgraduate Award (UK), and during 2002- 2004, he has rewarded Postgraduate fellowship.
Dr. Chang is the Lab Chief for the Laboratory of Neurodegenerative Diseases in the School of Biomedical Sciences, member in The State Key Laboratory of Brain and Cognitive Sciences. Dr. Chang is also the Founder and Secretary of HKU Alzheimer’s Disease Research Network. He organizes International Alzheimer’s Disease Conference every year since 2000. Dr. Chang received his undergraduate training in Biochemistry in Hong Kong learning neurochemistry. He then learnt neuroimmunology, neuroanatomy and neurochemistry for his MPhil study. He moved to University of Munich, Institute for Surgical Research in Germany for his PhD working on clinical neuroscience and neurophysiology. Afterwards, he moved to National Institutes of Health for his postdoctoral training working on molecular neuroscience and neuropharmacology. Dr. Chang’s research interest is pathophysiological changes of Alzheimer’s disease (AD) and the risk factors (depression, cigarette smoking, systemic inflammation, and environmental toxins) leading to AD. He has published over 120 peer-reviewed papers and 14 book chapters in these areas. His h-index is 42 by Google-Scholar and 34 by Scopus. Dr. Chang is in the Scientific Advisory Board of International AD/PD Symposium, Scientific Review Committee in Alzheimer Association. He is the handling associate editor in Journal of Alzheimer’s Disease, and Senior Editor for Journal of Neuroimmune Pharmacology. He is the member of editorial board of more than 20 different journals. He is also a grant reviewer for many different grant agencies/Foundations. Dr. Chang is now the Editor-in-Chief of the ‘American Journal of Alzheimer’s Disease and Other Dementias, which has 20 years history in Alzheimer’s disease field.
Alzheimer’s disease; Parkinson’s disease; Glaucoma; Depression; Systemic inflammation; Herbal medicine
Dr. Chang has published over 120 peer-reviewed papers and 14 book chapters on pathophysiological changes of Alzheimer’s disease (AD) and the risk factors (depression, cigarette smoking, systemic inflammation, and environmental toxins) leading to AD.
Aswin is an NIHR Academic Clinical Fellow (Imperial College London) and Neurosurgical Trainee (North Thames Rotation). He is also the chair of the British Neurosurgical Trainee Research Collaborative. His current research focuses on the translational potential of therapies for spinal cord injury and regeneration under the supervision of Prof Simone di Giovanni. Aswin trained in Medicine at the University of Cambridge (MA) and University of Oxford (BMBCh) before taking up an academic foundation post at the University of Cambridge. His research focussed on neurotrauma, in particular the surgical and medical management of chronic subdural haematoma, under the supervision of Prof Peter Hutchinson and Mr Angelos Kolias. He is currently an investigator on the NIHR HTA-funded Dex-CSDH trial, a randomised controlled trial of dexamethasone vs placebo in patients with chronic subdural haematoma.
Neurosurgery; Anything to do with the inflammatory components of brain injury; Brain tumours and cerebrovascular disease
Dr. Jiu Chen is currently the committee member and secretary of China council for the promotion of health care international exchange- Cognitive Impairment Branch, and Department of Neurology in Affiliated ZhongDa Hospital of southeast university. He received his MD in 2013 from the Fourth Military Medical University in 2013 and Ph.D degree in 2017 from the Medical School of Southeast University. He had neuroimaging research training as visiting scholar at Medical College of Wisconsin in 2016, USA. He engaged in the research of the pathogenesis of subjects (late-life depression and mild cognitive impairment) at high risk to Alzheimer’s disease and developing prognostic model for predicting MCI-to-AD progression by using the multi-modal MRI and event related potential (ERP) approaches.
Neuropsychiatric Disorder (MCI: Mild cognitive impairment, AD: Alzheimer Disease); Mental Disease (Depression, Schizophrenia); Functional magnetic resonance imaging (fMRI); Event related potential (ERP); Neuroimaging; Cognitive Neuropsychology; Cognitive Neuroscience
1. Baosteel Awards in 2016;
2. National scholarship for graduate students in 2016;
3. The 3rd Award for Science and technology progress of in Shaanxi province in 2016. (Ranking No. 5);
4. A scholarship under the State Scholarship Fund in 2015;
5. National scholarship for graduate students in 2015;
6. Outstanding graduate student of Southeast University in 2015;
7. Outstanding Conference Speech Paper Award, the 12th annual Basic and Clinical Psychiatry Conference of the Chinese Society of Neuroscience and Psychiatry (CSNP) in 2015, Taiyuan;
8. Outstanding Paper Award, 4th National Academic Meeting of Dementia and Cognitive Impairment in 2015, Beijing;
9. The 2ndAward for Science and technology progress of Henan province in 2014. (Ranking No. 4);
10. Top Articles In Outstanding S&T Journal Of China, Frontrunner 5000 in 2013;
11. Outstanding Paper 1st Award, Shaanxi Annual Meeting of Psychiatry and Mental Health in 2012;
12. Outstanding Paper 2nd Award, Shaanxi Annual Meeting of Psychiatry and Mental Health in 2011.
Dr. Xingyong Chen graduated from Sun Yat-Sen University and got MD and PhD of neurology, and he is currently associate professor of Fujian Medical University. He works in department of neurology, Fujian Provincial Hospital, Fujian Medical University. He devotes himself to basic and clinical researches of stroke and neuroinflammation and neurodegenaration.
Cerebrovascular disease; Neuroinflammation; Neurodegenaration
Till now, Dr. Xingyong Chen has published several high-quality articles about his research areas.
Dr. Yan Chen is currently associate professor of Huashan Hospital affiliated to Fudan University. She graduated from Shanghai Medical University in 1996. Subsequently, she worked as resident in department of neurology in Huashan hospital. She got MD and PhD of neurology in Fudan University. Her Clinic practice and research mainly focused on Motor Neuron Disease and dystonia.
Clinic practice and research mainly focused on Neurodegeneration disease, such as Motor Neuron Disease, Parkinson disease, dystonia.
Till now, Dr. Yan Chen has published several high-quality articles about his research areas.
Prof. Chen is Professor with tenure in the Neuroscience Center of Excellence, Louisiana State University Health Sciences Center. He graduated from Nanjing University in 1983 and continued his training in Physiology from Zhejiang University School of Medicine. Dr. Chen received his PhD degree in Physiology in 1993 from Tulane University, New Orleans, USA.
Neuroscience; Neuroinflammation; Synaptic plasticity; Neurodegenerative diseases; Alzheimer’s disease; Traumatic brain injury; Endocannabinoids; COX-2, Learning and memory
Till now, Prof. Chu Chen has published 60 high-quality articles about his research areas.
Dr. Davis received his BS in biomedical sciences from Oklahoma State University in 1990. In 1994 he received a MS in zoology from Oklahoma State University. Then in 1998 he earned a PhD in nutrition from Texas Tech University; followed by six years (1998 to 2004) of training in pharmacology and neuroscience as a Postdoctoral Research Associate at the Texas Tech University Health Sciences Center. In 2004 Dr. Davis joined the faculty at Oklahoma State University Center for Health Sciences in Tulsa, OK, where he is currently Professor of Pharmacology and Director of the Biomedical Sciences Graduate Program.
Neuroinflammation, CNS disorders such as Parkinson’s disease, HIV-dementia and mood/behavior disorders, inflammatory signaling in astrocytes and microglia and modulation of these signaling events by drugs of abuse and other pharmacologic agents
Dr. Ginsberg’s editorial responsibilities include serving as Academic Editor for PLoS One and Associate Editor for Translational Neuroscience. Steve also currently serves on the Editorial Board of 8 journals, and acted as Guest Editor/Section Editor for 3 journal issues.
Dr. Ginsberg sits on Advisory Boards for the Autism Tissue Program (ATP) tissue advisory board (TAB) and the Rett syndrome International Rett Syndrome Foundation (IRSF). Dr. Ginsberg is the Chairman of the Institutional Animal Care and Use Committee (IACUC) at the Nathan Kline Institute (NKI). Steve is a member of the Department of Psychiatry Appointments and Promotions Committee (DAPC) at the New York University Langone Medical Center (NYULMC), and is part of the Center for Cognitive Neurology at NYULMC.
Anatomy and histology; Pathology; Genetics; Diet therapy
Dr. Konstantin Balashov, MD, PhD, FAAN, is a Professor of Neurology at Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ. He sees patients at the Robert Wood Johnson Center for Multiple Sclerosis, is actively involved in clinical trials and research on multiple sclerosis, and teaches medical students and neurology residents. He is board-certified in both Neurology and Neuroimaging.
Dr. Balashov received his MD and PhD degrees from the Russian State Medical University and Russian Academy of Medical Sciences, Moscow. He graduated from the Neurology Residency Program as Chief Resident at the New Jersey Neuroscience Institute in Edison, NJ and completed fellowship training in multiple sclerosis/neuroimmunology at Harvard Medical School under the mentorship of Dr. Howard Weiner.
Dr Balashov’s clinical research projects have been funded by the National Institutes of Health, National Multiple Sclerosis Society, and other research foundations. He is the author of more than 50 original papers and reviews published in academic journals such as Proceedings of the National Academy of Sciences USA; Annals of Neurology; Neurology, and Multiple Sclerosis Journal.
Till now, Dr. Konstantin Balashov has published more than 50 high-quality articles about his research areas.
He is the deputy head of the nerve infection and cerebrospinal fluid cytology group of the Chinese Medical Association neurology branch, the deputy director of the Specialized Committee the Nerve infection diseases of Chinese Medical Doctor Association nerve branch of Neurology, the member of the standing committee of stroke and vertigo society of Chinese stroke society, Director of Neurology Department of cardiovascular and cerebrovascular disease hospital of Ningxia Medical University. He has long been engaged in clinical research on central nervous system infection, cerebrospinal fluid cytology, cognitive impairment, dementia, vertigo and cerebrovascular diseases. He has published more than 40 papers, edited 5 books, the provincial science and technology progress awards 2, presided over the 4 provincial and ministerial research projects, training more than 20 postgraduates.
Neurology common diseases such as cerebrovascular disease, central nervous system infection, epilepsy, dementia, dizziness and neurologist difficulty of diagnosis and treatment of diseases such as the treatment of critically ill patients; Central nervous system infection, and cerebrospinal fluid cytology and cognitive dysfunction and dementia research work
Dr. Vicente Felipo is Director of the Laboratory of Neurobiology and of the Program on Neuroinflammation and Neurological Impairment of the Centro de Investigacion Principe Felipe in Valencia (Spain). He has 30 years of experience in the research on the mechanisms, diagnosis and treatment of the neurological alteration in hyperammonemia, hepatic encephalopathy, by exposure to food and environmental contaminants and in other pathological situations. Vicente Felipo has authored more than 270 manuscripts, 3 patents, co-edited 7 books, organized more than 20 International Symposia and directed more than 20 doctoral theses. He has been first Secretary of the International Society for Hepatic Encephalopathy and member of different national and international Committees.
Neurobiology; neurotransmission; Neuroinflammation; Hyperammonemia; Hepatic encephalopathy; Cognitive function; Learning and memory; Motor coordination; GABAergic neurotransmission; Glutamatergic neurotransmission; NMDA receptors; AMPA receptors; GABA transporters
Till now, Dr. Vicente Felipo has published 290 high-quality articles about his research areas.
Dr. Yara Dadalti Fragoso is a Neurologist with further Master and Doctor degrees, areas of expertise concentrated on demyelinating diseases and headaches.
At present I’m Head of the Department of Neurology in Universidade Metropolitana de Santos, SP, Brazil and I coordinate Brazilian study groups on clinical, epidemiological and therapeutic aspects of a variety of neurological diseases.
Prospective database on pregnancy and multiple sclerosis; Treatment of headache and epilepsy in children and adolescents; Prospective database of pharmacovigilance on new drugs for the treatment of MS; Treatment of multiple sclerosis and neuromyelitis optica in children and adolescents
Till now, Dr. Yara Dadalti Fragoso has published 85 high-quality articles about his research areas.
Chaitali Ghosh received her PhD in Toxicology from the Indian Institute of Toxicology Research, Lucknow (India) and Hamdard University, New Delhi (India) with subsequent postdoctoral training in Vascular biology and Epilepsy at the Cleveland Clinic (USA). She is currently an Assistant Professor in Molecular Medicine at the Cleveland Clinic Lerner College of Medicine and Case Western Reserve University. She leads the Brain Physiology Laboratory in the Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute.Her research is funded by grants from the National Institutes of Health, American Heart Association, Alternative Research and Development Foundation, and Brain and Behavior Research Foundation.
Neurobiology; Blood-brain barrier; Drug resistant epilepsy; Neuropharmacology; Toxicology
1. Peer review committee member in several scientific journals. 2. Active member in American Epilepsy Society and American Heart Association. 3. PubMed publication list (*Note: under “Sinha C” and “Ghosh C”):PubMed
Dr. Sara G.M. Piccirillo graduated at the University of Milan (Italy) in Medical Biotechnology in 2003. She gained a PhD in Translational and Molecular Medicine in 2008 at the University of Milan-Bicocca and worked as Research Associate at the Department of Clinical Neurosciences of Cambridge University (UK) in 2010-2016. During this time, she was awarded a Marie Curie Intra-European Fellowship and in February 2011 she was elected Research Fellow of Hughes Hall, the oldest graduate college of the University of Cambridge. In 2014 she has received an Honorary Master Degree from the same University.
In 2016 she has been awarded a CRUK New investigator Research Award to launch her independent career and in the same year she has joined UT Southwestern Medical Center in Dallas (Texas) as Faculty Member in the Department of Internal Medicine.
In total, she has co-authored 25 scientific articles and reviews and 3 book chapters. In the last years, she has acted as reviewer for more than 10 international peer-review journals. She is Editorial Board Member of Neuroimmunology and Neuroinflammation since 2013.
Neural stem cells and brain tumors; Brain tumours and cancer stem cells of the brain with a focus on intra-tumour heterogeneity and phenotypic and molecular characterization of gliomas
2016 New Investigator Research Award granted by Cancer Research UK;
2014 Master of Arts (Honorary), Hughes Hall College, University of Cambridge;
2011–2016 Research Fellow at Hughes Hall College, Cambridge, UK;
2011–2013 Marie Curie Intra-European Fellowship For Career Development by the European Commission under the Seventh Framework Programme;
2010 Young Investigator Award 2010 by British Neuro-Oncology Society (BNOS) and Brain Tumour UK;
2007 Best Young Italian Researcher 2007-Premio Sapio award granted by SAPIO group;
2005 Translational Research Excellence Award by Brain Tumour UK.
Dr. Grebenciucova is an academic neurologist at Northwestern University Feinberg School of Medicine/ Northwestern Memorial Hospital, Chicago, IL. She completed her fellowship in Multiple Sclerosis and other inflammatory disorders of the central nervous system at the University of Pennsylvania, Philadelphia, PA and her neurology residency at the University of Chicago, Chicago, IL. Dr. Grebenciucova’s research interests lie in the areas of multiple sclerosis, neurosarcoidosis, autoimmune encephalitis and neurologic infections.
Multiple sclerosis; Neuromyelitis optica; Neurosarcoidosis; Transverse myelitis, Inflammatory disorders of central nervous system；CNS infections；HIV；PML
To date, Dr. Elena Grebenciucova has published several high-quality articles about her research areas.
Professor Hongzhi Guan. M.D. is a Neurologist, neuropathologist and cytologist of Department of Neurology in Peking Union College Hospital(PUMCH) and Chinese Academy of Medical Sciences. He is laso Director of Program of Encephalitis and Paraneoplastic Syndrome of PUMCH and Director of Cerebrospinal Fluid Cytology in PUMCH. He is Committee member of Chinese Society of Neuroinfection and Cerebrospinal Fluid Cytology of Chinese Medical Association. He is Vice Chairman of the Neuroimmunology and Neuroinfection Society of Beijing Neurology Association. He is Founder and director of Beijing Encephalitis Society (BES) and Clinical CSF Cytology Conference (CCCC).
Professor Guan signs over 10,000 reports of CSF cytology and autoantibody test annually. His team is engaged in treatment and research of autoimmune encephalitis and CNS infectious disease.
Autoimmune encephalitis; Anti-NMDA receptor encephalitis; Limbic encephalitis; Paraneoplastic neurological syndrome and CSF cytology
Prof. Jun-Ying He is a director of Neurology at the Second Affiliated Hospital of Hebei Medical University, a chief physician, and a postgraduate tutor. She also serves as deputy team leader for Infection and Cerebrospinal Fluid Study Group in Neurology Branch of Chinese Medical Association. She has a deeper study on infectious disease of central nervous system. The cytomorphology examination in cerebrospinal fluid she developed for the diagnoses of meningeal carcinomatosis, achieves the domestic leading level. She has undertaken a number of national and provincial research projects for the past years. She serves as editorial board member of Chinese Journal of Brain and Neurological Diseases.
Central nervous system infectious disease and carcinomous meningeal
Dr. Janice Ho is an Assistant Professor in the School of Nursing, The Hong Kong Polytechnic University. She earned her Ph.D. degree from The University of Hong Kong and she is also a registered Chinese medicine practitioner. Her research has been focused on neurodegeneation and neuroprotective herbs. She is an expertise in molecular and animal studies for neurodegenerative diseases. Currently, her projects are related to risk factors of dementia. She also works on clinical trials for symptom management in the elderly.
Chinese Medicine for the treatment and prevention of aging-associated degenerative diseases (Alzheimer’s disease and Parkinson’s Disease) and mental disorders (depression) by elucidating the molecular mechanisms of neuroprotective herbs and conducting clinical studies on the effectiveness of Chinese Medicine interventions
Prof. Tibor Hortobágyi is an academic neuropathologist, head of department and chair at the University of Debrecen, Hungary, and reader in Old Age Psychiatry at King’s College London, UK. His main research interest is neurodegeneration, cerebrovascular diseases, and traumatic brain injury and brain tumours. Tibor Hortobágyi is author on more than 130 research papers and numerous book chapters, with publications in Science and Nature Neuroscience, and editorial board member of several journals. He is councillor of the European Confederation of Neuropathological Societies (EURO-CNS) and International Society of Neuropathology (ISN). He is devoted to neuropathology teaching and is Chairman of the Board of Examiners of the European Neuropathology Exam (EFN) and Advisor at the International Department of the Royal College of Pathologists.
Neuropathology; Neurodegeneration; Cerebrovascular disease; Brain tumours
Neuropathological characterization of specials distinct subtypes of neurodegenerative diseases. Clinicopathological studies in neurodegenerative and cerebrovascular diseases and brain tumours with identification of prognostic and diagnostic markers. Characterization of a novel model of traumatic brain injury. Early detection of axonal injury in brain trauma.
Dr Grant Hill-Cawthorne is a medical microbiologist and the Senior Lecturer in Communicable Disease Epidemiology at the Marie Bashir Institute and School of Public Health, University of Sydney. After completing medicine and medical training at the University of Cambridge he went to Saudi Arabia where he set up a laboratory specialising in pathogen genomics. His PhD was in the use of genomics for public health microbiology and as part of this he led a large worldwide study on TB genomics as well as studies on total drug resistant TB in South Africa. His ongoing research is on the use of molecular epidemiology for public health policy, particularly focusing on emerging infections, drug resistance and the impact of mass gatherings. Grant is the unit coordinator for the communicable disease units within the Master of International Public Health and Master of Public Health. He has also co-developed a new degree: the Master of Health Security.
Infectious diseases; Microbiology, Genomics; Mass gathering medicine; Neurological infections
Dr Grant Hill-Cawthorne has rewarded Honorary Life Fellow, St. Andrew’ s College; he has applied for >$7,000,000 research funding in past 5 years and has 42 publications with the H index 11.
Prof. Chaur-Jong Hu graduated from School of Medicine, College of Medicine, Taipei Medical University (TMU) and received his Neurology training in Taipei Municipal Jen-Ai Hospital, Taipei, Taiwan. Now, he is professor and chief of neurology, TMU, also vice superintendent and the director of department of Neurology and dementia center in Shuang Ho Hospital, TMU. He has ever been a research fellow in stroke center, Washington University, St. Louis US in 2000. He devotes himself to basic and clinical researches of stroke and dementia after he came back to Taiwan. His recent researches include the connectones of fMRI in the ischemic stroke and genetic, epigenetic researches of Alzheimer disease. He is one of the founders of Taiwan Dementia Society (TDS). He joins the national collaboration stroke and dementia network, including Taiwan stroke registry, biosignature of stroke, biosignature of dementia and Taiwan stroke trial consortium and a few international clinical trials for stroke and Alzheimer disease. He has published over 100 research papers in peer-reviewed journals. He also serves as a reviewer for over 30 journals. He became a fellow of American Heart Association (FAHA) in 2015.
Stroke; Molecular neurology; Dementia
Prof. Chaur-Jong Hu has been authors or co-authors on over 130 papers in peer-reviewed journals, and served as a reviewer for over 40 peer-reviewed journals.
Dr. Li-Fang Hu studied in Nanjing Medical University from 1997 till 2005, and got her Bachelor and Master degree in 2002 and 2005, respectively. She obtained the PhD degree in the department of Pharmacology in National University of Singapore. She joined in the Institute of Neuroscience in Soochow University in 2010, and was promoted as a PI of Parkinson’s disease (PD) research group in 2015. Her lab focuses on studying the molecular pathogenesis of PD. In recent years, her team studied the role of autophagy in glia biology and the interaction between autophagy and inflammatory responses in glial cells. Since 2010, she and her team has already published more than 20 articles in peer-reviewed journals, such as Autophagy, Brain Behavior Immunity and Aging cell. Now she is a member of the Chinese and American Society for Neuroscience, and serves as the peer reviewer in several SCI journals. As a young PI, she got several grants including the National Natural Science Foundation of China (81171212/81571233), the National Key R&D Program of China (2016YFC1306002), and Natural Science Foundation of Jiangsu Province (BK2011294). She was also elected as ‘high-level creative and innovative talent in Suzhou City’ (2011).
Neuroprotection and molecular pathogenesis of Parkinson's disease; Neuroinflammation (inflammation mediators) and Neurology (physiology and pathology)
June 2016 – to date:
Assistant Professor of Molecular Biology, Dept. BIOMETEC, University of Catania
• Neural stem cells
• Glial cells
• Parkinson’s disease
• Molecular mechanisms of CNS neuroprotection and repair
• Cell-to-cell communication via extracellular vesicles, including exosomes
• Horizontal RNA transfer (coding and non-coding)
• Nanotechnologies and Synthetic Biology
February 2011 – May 2016:
Research Fellow at the Dept. of Clinical Neurosciences, University of Cambridge.
Supervisor: Stefano Pluchino, MD, PhD
• Somatic and embryonic stem cells
• Neural stem cells
• CNS regeneration
• Molecular mechanisms of neuroprotection and cell-to-cell communication
• Extracellular vesicles (EVs), including exosomes
• Horizontal RNA transfer (coding and non-coding)
• Nanotechnologies and Synthetic Biology
January 2009 – January 2011:
Postdoctoral activity at the Dept. of Biology, University of Bologna.
Subjects of research:
• MYCN-mediated transcriptional repression in neuroblastoma
• MYC as a regulator of ABC genes in Chronic Myeloid Leukemia (CML) CD34+ hematopoietic progenitor cells
• Role of IKAROS in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL)
• Identification of novel miRNAs suppressing BCR-ABL expression in CML
Supervisor: Professor Giovanni Perini, PhD.
January 2006 – December 2008:
PhD studentship at the Dept. of Biology, University of Bologna.
• “Complexity of MYCN transcriptional function in childhood neuroblastoma.”
Supervisor: Professor Giovanni Perini, PhD.
April 2004 – December 2005:
Undergraduate/graduate studentship at the Dept. of Biology, University of Bologna.
• “Transcriptional induction of TRKA and p75NTR genes in neuroblastoma by histone deacetylase inhibitor Trichostatin A (TSA).”
Supervisor: Professor Giovanni Perini, PhD.
Molecular biology; Neurosciences
• “Brains2South” grant (Fondazione con il Sud - Bando Capitale Umano ad Alta Qualificazione 2015): “Characterization of exosomes as natural messengers of bioactive molecules in the glial-neuronal signaling in Parkinson's disease.” Principal Investigator, amount granted for 3 years: € 250,000. Dept. BIOMETEC, University of Catania.
• Emerging Research Leaders’ Development Programme (ERLDP) 2014, organised by the University of Cambridge: selected (after application).
• The Evelyn Trust 2013 grant: “Cell signalling through secreted extracellular RNAs in neuro-immune interactions.” Co-applicant, amount granted: £ 244,565. From December 2013 to November 2015. Dept. of Clinical Neurosciences, University of Cambridge
• The FEBS Long-Term Fellowship: “Mechanisms of mobile ncRNAs in stem cells.” From December 2011 to November 2013. Dept. of Clinical Neurosciences, University of Cambridge
• “Centro Interdipartimentale di Ricerca sul Cancro Giorgio Prodi” Fellowship: "Eradication of acute and chronic leukemic stem cells through interference of the self renewal mediated by the Smo Inhibitors." From January 2010 to December 2010, at the Department of Biology - University of Bologna.
• NOVARTIS Fellowship: "Identification and characterization of microRNAs that block the function of Bcr-Abl in Philadelphia positive leukemias." From January 2009 to December 2009, at the Department of Biology - University of Bologna.
• Award “Premio di Operosità”: "Transcriptional mechanisms mediated by oncoprotein N-Myc in neuroblastoma.” Granted by NOVARTIS in February 2008, at the Department of Biology - University of Bologna.
Dr. Jiang is a Professor of Neurology and Deputy Director of Department of Neurology in Xijing Hospital (Xi’an, China). He obtained his medical degree in 1993 from Fourth Military Medical University in China and completed his neurology residency training in Xijing Hospital. In 2002, Dr. Jiang received his PhD degree in Neurology from Fourth Military Medical University. During 2013-2015, he conducted his postdoctoral research at University of Saskatchewan. Dr. Jiang' clinical research and laboratory research interest is in epilepsy, stroke and neurocritical care.
Neurology; Neurocritical care
1.Li W, Sun X, Yuan F, Gao Q, Ma Y, Jiang Y, Yang X, Yang F, Ma L, Jiang W*. Diagnostic Accuracy of Cerebrospinal Fluid Procalcitonin in Bacterial Meningitis Patients with Empiric Antibiotic Pretreatment. J Clin Microbiol. 2017, 55(4):1193-1204.
2.Jiang YL, Yuan F, Yang F, Sun XL, Yang XA, Song L, Jiang W*. Prognostic analysis for short- and long-term outcomes of newly diagnosed epilepsy. Seizure. 2017, 47:92-98.
3.Ma Y, Sun X, Li J, Jia R, Yuan F, Wei D, Jiang W*. Melatonin Alleviates the Epilepsy-Associated Impairments in Hippocampal LTP and Spatial Learning Through Rescue of Surface GluR2 Expression at Hippocampal CA1 Synapses. Neurochem Res. 2017, 42(5):1438-1448.
4.Zhang J, Yang XA, Zhang Y, Wei JY, Yang F, Gao H, Jiao WW, Sun XL, Gao Q, Jiang W*. Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China. J Stroke Cerebrovasc Dis. 2017, 26(1):125-131.
5.Ma Y, Sun X, Li W, Li Y, Kang T, Yang X, Jiang W*. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) with intracranial Epstein-Barr virus infection: A Case Report. Medicine (Baltimore). 2016 Nov;95(46):e5377.
6.Sun XL, Chen BY, Zhao HK, Cheng YY, Zheng MH, Duan L, Jiang W*, Chen LW. Gas1 up-regulation is inducible and contributes to cell apoptosis in reactive astrocytes in the substantia nigra of LPS and MPTP models. J Neuroinflammation. 2016, 8;13(1):180.
7.Yang F, Sun X, Ding Y, Ma H, Yang TO, Ma Y, Wei D, Li W, Xu T, Jiang W*. Astrocytic Acid-Sensing Ion Channel 1a Contributes to the Development of Chronic Epileptogenesis. Sci Rep. 2016, 6:31581.
8.Gao Q, Ou-Yang TP, Sun XL, Yang F, Wu C, Kang T, Kang XG, Jiang W*. Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Crit Care. 2016 Feb 25;20(1):46.
9.Ou-Yang TP, Zhu GM, Ding YX, Yang F, Sun XL, Jiang W*. The Effects of Amiloride on Seizure Activity, Cognitive Deficits and Seizure-Induced Neurogenesis in a Novel Rat Model of Febrile Seizures. Neurochem Res. 2016, 41(4):933-42.
10.Kang XG, Yang F, Li W, Li L, Jiang W*. Predictive value of EEG-awakening for behavioral awakening from coma. Annals of Intensive Care. 2015, Dec; 5(1):52. doi: 10.1186/s13613-015-0094-4.
11.Ma L, Li XW, Zhang SJ, Yang F, Zhu GM, Yuan XB, Jiang W*. Interleukin-1 beta guides the migration of cortical neurons. J Neuroinflammation. 2014; 11: 114. doi: 10.1186/1742-2094-11-114.
12.Ma L, Wang L, Yang F, Meng XD, Wu C, Ma H, Jiang W*. Disease-Modifying Effects of RHC80267 and JZL184 in a Pilocarpine Mouse Model of Temporal Lobe Epilepsy. CNS Neurosci Ther. 2014; 10: 1489-1495.
13.Wei D, Yang F, Wang Y, Yang F, Wu C, Wu SX*, Jiang W*. Degeneration and regeneration of GABAergic interneurons in the dentate gyrus of adult mice in experimental models of epilepsy. CNS Neurosci Ther. 2014,21:52-60.
14.Gao F, Liu ZQ, Ren W*, Jiang W*. Acute lipopolysaccharide exposure facilitates epileptiform activity via enhanced excitatory synaptic transmission and neuronal excitability in vitro. Neuropsychiatr Dis Treat. 2014; 10: 1489-1495.
15.Wang XM, Jia RH, Wei D, Cui WY, Jiang W*. MiR-134 blockade prevents status epilepticus like-activity. Neurosci Lett. 2014; 572:20-25.
16.Meng XD, Wei D, Li J, Kang JJ, Wu C, Ma L, Yang F, Zhu GM, Ou-Yang TP, Liu YY*, Jiang W*. Astrocytic expression of cannabinoid type 1 receptor in rat and human sclerotic hippocampi. Int J Clin Exp Pathol. 2014; 7(6): 2825-2837.
17.Li L, Kang XG, Qi S, Xu XX, Xiong LZ, Zhao G, Yin H*, Jiang W*. Brain response to thermal stimulation predicts outcome of patients with chronic disorders of consciousness. Clin Neurophysiol. 2014, 126:1539-47.
18.Kang XG, Li L, Wei D, Xu XX, Zhao R, Jing YY, Su YY, Xiong LZ, Zhao G, Jiang W*. Development of a simple score to predict outcome for unresponsive wakefulness syndrome. Crit Care. 2014;18(1):R37.
19.Zeng WZ, Liu DS, Duan B, Song XL, Wang J, Wei D, Jiang W, Zhu MX，Li Y, Xu TL*. Molecular mechanism of constitutive endocytosis of Acid-sensing ion channel 1a and its protective function in acidosis-induced neuronal death. J Neurosci. 2013; 17; 33(16): 7066-78.
20.Li XW, Yang F, Wang YG, Wang JC, Ma L*, Jiang W*. Brain recruitment of dendritic cells following Li-pilocarpine induced status epilepticus in adult rats. Brain Res Bull. 2013; 91:8-13.
21.Gao F, Liu YF, Li XW, Wang Y, Wei D, Jiang W*. Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model. Pharmacol Biochem Behav. 2012; 103(2): 187-96.
22.Li XW, He H, Liu YF, Gao F, Wei D, Meng XD, Ma L*, Jiang W*. Effectiveness and safety assessment of lamotrigine monotherapy for treatment of epilepsy. Eur Rev Med Pharmacol Sci. 2012; 16(10): 1409-1413.
23.Ma L, Cui XL, Wang Y, Li XW, Yang F, Wei D, Jiang W*. Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats. Brain Res. 2012; 1469: 103-113.
24.Liu YF, Gao F, Li XW, Jia RH, Meng XD, Zhao R, Jing YY, Wang Y*, Jiang W*. The anticonvulsant and neuroprotective effects of baicalin on pilocarpine-induced epileptic model in rats. Neurochem Res. 2012; 37(8): 1670-80.
Sofia Kasradze is the Associated Professor of Neurology at the Medical Faculty of the Caucasus International University, Tbilisi, Georgia. She is one of the founder and Scientific director of the Institute of Neurology and Neuropsychology. She is the expert on Epilepsy of the Ministry of Health of Georgia and Director of the National State Program on Diagnosis and Treatment of Epilepsy in Georgia. Also Mrs. Kasradze is the Secretary General of the Georgian Chapter of International League Against Epilepsy, President of the Georgian Sleep Research and Sleep Medicine Society and Expert on National Guidelines and Protocols on Epilepsy.
Professor Yun-Bae Kim had got PhD degree at College of Veterinary Medicine of Seoul National University, Korea, in 1996. He has been teaching students at Department of Toxicology, College of Veterinary Medicine, Chungbuk National University, Korea, since 2002. Dr. Kim has studied on the neurotoxicopathology of chemicals and neurodegenerative diseases as well as brain aging, and published 322 research papers. Especially, his recent research has been focusing on stem cells encoding functional genes for neurodegenerative diseases such as Alzheimer disease and senescence, cerebral palsy, multiple sclerosis, Lou Gehrig disease, Stroke, Parkinson disease, etc, since he successfully developed neural stem cells effective for Alzheimer dementia as a visiting professor at University of British Columbia, Canada, in 2011. Professor Kim has served as Editor-in-Chief of Laboratory Animal Research for 10 years, and is working as a CEO of Designed Cells Co., Ltd. to develop stem cells for Alzheimer disease therapy.
Transplantation immunology; Inflammation; Inflammation mediators; Pathology; Cerebrospinal fluid
Dr. Jun-ichi Kira is Professor and Chairman in Department of Neurology, Neurological Institute, Graduate School of Medical Sciences at Kyushu University. Dr. Dr. Jun-ichi Kira’s Current Research Areas include Immunologic and genetic studies of multiple sclerosis, Clinical and immunological studies of atopic myelitis, and Biological studies of motor neuron diseasesand Alzheimer disease.
Neuroimmunological research on multiple sclerosis (Multiple sclerosis, genetic polymorphism, MRI, C-MS, OS-MS, Neuromyelitis optica, Balo disease); Cell biological research on motor neuron diseases (moter neuron disease, ALS, cytokine, growth factors, G-CSF)
Dr. Klegeris graduated with a M.Sc. in Biophysics from Moscow State Medical University. He then entered Oxford University, UK where he received his D Phil in Pharmacology in 1995. Towards the end of his studies at Oxford he became interested in inflammatory responses of the central nervous system particularly involving microglial cells. This led him to the University of British Columbia for post-doctoral studies in the Kinsmen Laboratory of Neurological Research. He was promoted to Research Associate in the Department of Psychiatry in 1999 and, in 2007 became an Assistant Professor of Pharmacology in the Department of Biology, UBC Okanagan in Kelowna , B.C. Identification of novel treatment options for neurodegenerative disease is the main research focus of the Laboratory of Cellular and Molecular Pharmacology which is currently under development. He teaches undergraduate courses in pharmacology and biochemistry.
Novel pharmacological approaches in alzheimer’s disease; Novel therapeutic approaches to neurodegenerative disease; Regulation of brain glial cell functions by extracellularly released mitochondrial transcription factor a and microparticles; Identification of novel intercellular signaling molecules of the animal central nervous system
Dr. Koomoa was born and raised in Hawai’i. She obtained her Ph.D. in Molecular Pharmacology, Physiology and Biotechnology from Brown University, and completed her postdoctoral fellowship at the University of Hawaii Cancer Center. She is currently an Associate Professor at the University of Hawaii. Dr. Koomoa’s work focuses on elucidating the spatio-temporal development of calcium signaling that regulates NB cell survival and leads to drug resistance, and identifying molecular components that mediate these signals. Furthermore, as calcium signaling regulates the function of immune cells, she is also examining the spatio-temporal calcium signaling in immune cells in the NB tumor microenvironment.
Elucidating calcium signaling pathways that regulate fundamental physiological and pathophysiological processes; Understanding the signal transduction pathways, calcium signaling and ion channel physiology involved in the pathophysiology of different diseases such as depression, diabetes, neuroblastoma and other cancers
Prof. Bin Li works in the second hospital of Hebei medical university. She graduated from Hebei medical university in 1999, and received PhD in 2008. Her research focuses on neuroimmunology.
1. Prof. Li has rewarded the Second prize of Science and Technology Progress Award of Hebei Province;
2. Prof. Li has rewarded the First prize of Hebei Medical Science and Technology Award for twice;
3. Prof. Li has rewarded the Second prize of Science and Technology Progress Award of Shijiazhuang City for twice.
Dr. Hai-Feng Li got his Bachelor degree from Shandong Medical University in 1994,and got his Doctor degree from Beijing Medical University in 1999. During Feb to Aug 2009, he was a senior visiting scholar in Karolinska Institute. During 1999-2013, he worked in the Affiliated Hospital of Medical College, Qingdao University. He is now the vice-director of Neurology department, Qilu Hospital of Shandong University (from Aug 2013).
Myasthenia gravis; CNS demyelinating diseases; Autoimmune peripheral neuropathies; Cerebrovascular disease
Dr. Hai-Feng Li has established a database of myasthenia gravis cohort of more than 1500 patients and relevant biobank since 2007, and published a series of clinical, immunological and genetics research papers based on this cohort. He also published several clinical research papers and academic communications on CNS demyelinating diseases, autoimmune peripheral neuropathies and cerebrovascular disease.
Dr. Zhu-Yi Li, Professor of Neurology, is the Director of Department of Neurology in Tang Du Hospital of the Fourth Military Medical University. He graduated from the Fourth Military Medical University in 1985. He has been engaged in the prevention and treatment of myasthenia gravis in Department of Neurosciences in University of Oxford and Case Western Reserve University.
Dr. Li is currently the Vice Chairman of Neuroimmunology branch of Chinese Society for Immunology, Neuroimmunology Study Group of Chinese Society of Neurology, the Chairman of Chinese Society of Neurology, the Vice Chairman of Mobile Health branch of Chinese Stroke Association, Neuroimmunology Committee of Neurology branch of Chinese Medical Doctor Association, the Chairman of Shaanxi Neurology Association, the Associate Editor-In-Chief of Chinese Journal of Neuroimmunology and Neurology, and the Editorial Board Member of Chinese Journal of Neurology.
Being dedicated in researches of clinical Neurology, Dr. Li is proficient in neuroimmunology diseases such as the prevention and treatment of myasthenia gravis. Dr. Li had 9 research projects supported by Natural Science Foundation of China (NSFC), and 1 research project supported by Innovative Research Team Foundation of Ministry of Education. He has published more than 200 articles, 40 of which were published in journals indexed by SCI.
Dr. Liping Liu received her MD in 1993 from Medical College of Tongji University, Shanghai, China and Ph.D degree in 2002 from Medical Center of Fudan University, Shanghai, China. Subsequently, she had basic research training at National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH), Dept. of Microbiology and Immunology, College of Physicians & Surgeons, Columbia University and Cleveland clinic. Then she served as Research Associate staff. Currently she is a project staff at Dept. of Neurosciences, Lerner Research Institute, Cleveland Clinic, OH, USA.
Neuroinflammation; Neurodegeneration; Neuropathic pain; Stem cell therapy for pain and regeneration; Multiple sclerosis; Chemokine; Chemokine receptors
Till now, Prof. Liping Liu has published 31 high-quality articles about his research areas.
Prof. Zhenyu Liu received his Ph. D (with honors) in Pattern Recognition and Artificial Intelligence from the Institute of Automation, Chinese Academy of Sciences in 2014. Since then, he has been an assistant professor at the key laboratory of molecular imaging, Chinese Academy of Sciences. He mainly works on the medical image analysis and clinical applications. He has published more than 20 research articles in peer-reviewed journals including NMR in biomedicine, Plos One, JMRI and etc.
Medical image analysis; Clinical applications
Till now, Prof. Zhenyu Liu has published several high-quality articles about his research areas.
Dr Sofia Markoula received her MD in 1997 and her PhD in 2008 from the University of Ioannina, Greece. She has been working, as a Consultant Neurologist, since 2006 and, at present, she is a Senior Consultant at the Department of Neurology, Ioannina University Hospital, Greece, in charge of the Epilepsy Unit.
She has been trained in stroke, as visiting scholar in 2005, at the Stroke Unit, in Huddinge, Karolinska Institute, in Stockholm, Sweden, and has received clinical and research training in epilepsy from 2011-2012, working as Honorary Clinical Assistant at the Department of Clinical and Experimental Epilepsy, Hospital of Neurology and Neurosurgery, UCL Institute of Neurology, in London, UK.
She has been engaged in genetics and pharmacogenomics, since 2007, at the Laboratory of Clinical Genetics Medical School, University of Ioannina, Greece.
Epilepsy, experimental animal models in epilepsy, stroke, neurogenetics, pharmacogenomics, EEG-fMRI
Dr. Sofia Markoula has published several high-quality articles, in international peer review journals. She has been personally funded with a national grant to carry out her PhD in 2006 and participated in many national and international funded projects for epilepsy, multiple sclerosis, stroke and genetics.
Dr. S. Meenakshi-Sundaram (Dr. SMS), a neurologist from India, did his M.B.B.S. from Madurai Medical College, Madurai, MD in General Medicine from S.M.S. Medical College, Jaipur and D.M. (Neurology) from NIMHANS, Bangalore. He bagged the Gold Medal and Best Outstanding Student of the Year 2000, at NIMHANS and the best research paper award at the 10th Annual Conference of Indian Academy of Neurology (IAN), Lucknow, in the year 2002. He has many publications and is practising as a Senior Consultant in the Department of Neurosciences, Apollo Hospitals, Madurai for the last over 16 years. Acute stroke care and neuroelectrophysiology are his main areas of interest.
Stroke; Acute management and electrophysiology (ENMG)
Dr. Mohan is currently an assistant professor of neuropharmacology at Manchester University, College of Pharmacy in Fort Wayne, IN. In addition to excellence in research and teaching, Dr. Mohan served as the President for the North Central Florida Chapter of the Society for Neuroscience (SfN) from 2013 – 2014. Dr. Mohan is a member of the Society for Neuroscience (SfN), American Heart Association (AHA), International Society for Neuroimmunology, American Association of Pharmaceutical Scientist (AAPS), American Association of Colleges of Pharmacy (AACP) Dr. Mohan has taught and mentored numerous undergraduate and graduate students during his research career.
Blood - brain barrier anatomy; Brain injuries; Excitotoxicity; Heme; Inflammation mediators; Neurologic deficit; Neuronal injury; Neuronal survival; Neurons; Neuroprotection; Neurotoxic; Neurotoxicity; Pharmaceutical preparations; Postnatal; Pre-clinical; Signal transduction; Stroke; Subarachnoid hemorrhage; Therapeutic target; Toxic effect; Translational research
After graduation of the study at the Faculty of Pharmacy in Silesian School of Medicine (Katowice), she has been working at the Department of Pharmacology as a scientific worker. From 2006 Head of the Department of Pharmacology in School of Medicine, Medical University of Silesia in Katowice. At first she was engaged in the studies concerning various aspects of the influence of psychotropic drugs on neuropeptides (enkephalins, neuropeptide Y) in the brain of lab animals, and then in in vivo and in vitro experimental studies estimating the effect of psychotropic drugs on proinflammatory cytokines, neurotrophic factors and protein expressed in glial cells. Nowadays, she is interested in research on the interaction between stress and immunostimulation in modulation of neurotrophic factors (BDNF, VEGF) in the rat brain structures and periphery and also on the interaction between antidepressants and cytostatics applied in therapy of glioblastoma. Scientific achievements: author or co-author of 78 full-length papers; index Hirscha 15; author of 7 chapters in 3 handbooks concerning pharmacotherapy; three grant projects of the polish scientific committees; two Scientific Awards of Minister of Health and Social Welfare and nine Scientific Awards of Rector of Medical University of Silesia.
Neuropeptide Y-like immunoreactivity; BDNF and VEGF in the pathogenesis of stress-induced affective diseases; Brain disease, glioma
For the first time she observed that antidepressants (amitryptyline and nortryptyline) inhibit secretion of proinflammatory cytokines (IL-1beta, TNF-alpha) in rat mixed glial and microglial cell cultures activated by LPS; in rat mixed glial cell cultures imipramine inhibited the LPS-induced inflammatory response, prevented the morphological alterations elicited by LPS and in unstimulated cells caused transformation of microglia cells into cells with neuron-like morphology; sex differences in BDNF and VEGF systems under normal conditions and in response to peripheral given IL-1beta was described; different effects of antipsychotics on the balance between pro- and anti-inflammatory cytokines depends on glia activation.
He is a researcher at Inserm Eri24/University of Picardie Jules Verne (Amiens, France) and at MRC centre for synaptic plasticity/University of Bristol (Bristol, United-Kingdom), he has been awarded a Chair of Excellence funded by Région Hauts-de-France (France) in 2017. His works focus mainly on the deciphering of the cellular mechanisms associated with glutamatergic synaptic transmission inhibition within the brain. He currently studies the way alcohol poisoning (Binge Drinking), by inducing neuroinflammation, can interfere with Long term Depression (LTD), one of the major forms of synaptic plasticity required for learning and memory processes.
Glutamatergic receptors; Hippocampal synaptic plasticity (mainly Long Term Depression); Intracellular signalling pathway; Neuromodulation by cytokines and neuropeptides; Glia/neuronal interaction role on acute synaptic functioning; Electrophysiology; Pharmacology
Prof. George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist recognized in the field of Alzheimer's disease research particularly for his work in oxidative stress. Dr. Perry has studied at many universities and holds multiple degrees including a Bachelor of Arts degree in Zoology from the University of California Santa Barbara and a PhD in Marine Biology from the Scripps Institution of Oceanography at San Diego. He is distinguished as one of the top Alzheimer’s disease researchers by Expertscape with over 1000 publications, more than 67,000 citations (H=130), one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is a Semmes Foundation Distinguished University Chair in Neurobiology and is an active participant in many other scientific associations. He is an elected member of the Academies of Sciences of Mexico, Portugal, and Spain. In addition, Perry is an Editor of numerous scientific journals including Journal of Alzheimer’s Disease which he founded in 1998. Today, Perry continues his love for research while working as Dean of the College of Sciences at The University of Texas at San Antonio.
Neurodegeneration; Alzheimer’s disease; Effects of oxidative stress on the disease; Effects on other neurodegenerative disorders
• Sixth-most cited author of scientific papers in Alzheimer disease in the world
• One of the top 100 most-cited scientists in neuroscience and behavior and one of the top 25 scientists in free radical research
• Cited over 67,000 times and recognized as a highly-cited researcher by Thomson Reuters Web of Science, a comprehensive resource for searching and indexing scientists by discipline
• Editor-in-chief for the Journal of Alzheimer's Disease
• Fellow of American Association for the Advancement of Sciences
• Fellow of Microscopy Society of America, and past-president of the American Association of Neuropathologists
• Member of the Dana Alliance for Brain Initiatives, among the world’s most prestigious neuroscience groups
He is leading translational research on the immune-mediated mechanisms of amyloid-related imaging abnormalities (ARIA) in Cerebral Amyloid Angiopathy-related inflammation and immunotherapy of Alzheimer’s disease. He has >10 years experience in the discovery, validation and patenting of diagnostic, prognostic and therapeutic biomarkers and tools. He is the founding Member and Coordinator of the inflammatory Cerebral Amyloid Angiopathy and Alzheimer’s disease βiomarkers (iCAβ) International Network, 35 Centers/12 Countries World-Wide.
The definition of clinico-therapeutic recommendations and biomarkers to guide CAA and AD immunotherapy trials is the main goal of the biomarkARIA Project (P.I. Dr. Piazza) and iCAB Network, the largest worldwide effort aimed at deciphering the pathogenetic mechanisms of ARIA in a translational and cooperatively-open design between academia and pharma.
Cerebral amyloid angiopathy (CAA); Cerebral amyloid angiopathy-related inflammation (CAA-ri); ABRA; Alzheimer's disease; Cerebrospinal fluid; Biomarkers; Anti-Amyloid autoantibody; Disease Modifying Therapies for AD; Immunization in AD
Qi Xiao-kun is neurologist and the director of Dept. Neurology, Navy General Hospital, Bejing, who is also the director of Multidisciplinary Joint Consulting Center for Complicated Neurological Diseases. He is advisor of doctorial degree and master degree in clinical neurological specility for the Secondary Military Medical University and the Southern Medical University and the Dalian Medical University. He is a commissioner of Neurology Society in Chinese Medical Association(CMA); a commissioner of Neuroimmunology Branch of Neurology Society in CMA; a commissioner of Neuropathology Branch of Neurology Society in CMA; a director of Beijing Medical Association of CMA. He is the vice chairman of Neurology Society of the PLA Medical Science and Technology committee; the chairman of Neurology Society of Navy Medical Science and Technology Committee; the chairman of Neuroimmune and Neuromuscular Diseases Group in Neurology Society of the PLA Medical Science and Technology Committee. Now he is associate chief editor of Chinese Journal of Neuroimmunology and Neurology, an editor of Chinese Journal of Neurology, an editor of Chinese Journal of Internal Medicine ,etc. He has rich clinical experience in Neurology. More than 260 articles had been published individually. He chiefly edited three books. He got two items of Second Prize and seven items of Third Prizes of the PLA Medical Achievement.
Multiple sclerosis; Neuro myelitis opica; Myasthenia gravis; Multiple system atrophy
Prof. Majid Reza Farrokhi, now Professor of Neurosurgery, head of Shiraz Neuroscience Research Center, and Dean of Virtual School in Shiraz University of Medical Sciences, completed his Specialty Degree in Neurosurgery in 1996 and Fellowship of Spine Surgery at Innsbruck University in 2004. He has been the Vice President of Iranian Board of Examiners in Neurosurgery since 2012 and hold the position of the Chairman of Neurosurgery Department of Shiraz University of Medical Sciences in 2011-2014, Head of Fars and South of Iran AO-Spine Society in 2002-2005, and dean of Medical School, Bushehr University of Medical Sciences in 1996-1998. He has published more than 42 papers in reputed journals and 2 books and led several research projects.
Gianluca Serafini was born in Avezzano (L’Aquila), Italy, in 1978 from Italian parents. He took his degree in Medicine and Surgery at Sapienza University of Rome, becoming later psychiatrist. In 2012, he obtained his Ph.D. in Psychiatry: Early Interventions in Psychosis. From over ten years he worked as clinician and researcher at Sant’Andrea Hospital in Rome where from 2007 he is an active member of the Center for Suicide Prevention. His major research interests include neurobiology and neuroimaging of suicidal behaviour and major affective disorders, psychopharmacology, and neuroplasticity. He has been included in “2010 Marquis Who’s Who in the World”, “2011 Marquis Who’s Who in the World”, “2012 Marquis Who’s Who in the World”, “2013 Marquis Who’s Who in the World” and he is a fellow of several scientific Societies (New York Academy of Sciences, International Society for Affective Disorders, International Association for Suicide Prevention, Sociedad Española De Patología Dual, European Psychiatric Association (Secretary of the section Neuroimaging), Società Italiana di Psichiatria, Associazione Italiana Lotta allo Stigma). He is an active researcher being the author of more than 130 publications scientific contributions (author of more than 75 articles in peer reviewed international and national journals, author of approximately 40 book chapters, author of more than 20 abstract/posters in peer reviewed international journals). From 2007 he was a speaker in more than 105 national and international conferences and he is currently Editor-in-Chief of Journal of Life Medicine and Associate Editor of 2 international journals. He actually serves as reviewer for 57 peer-reviewed international journals, and he is Editorial/Advisory Board member of more than 20 peer-reviewed international journals.
Neurobiology of major neuropsychiatric disorders; Neuroimaging of major affective disorders and schizophrenia; Psychopharmacology; Amitriptyline; Neurogenic inflammation; Inflammation mediators; Anatomy and histology; Drug effects; Anatomy and histology; Diagnosis; Drug effects; Drug therapy; Epidemiology; Etiology; Physiopathology
1. 2002-2007: Department of Clinical Medicine, Shanxi Medical University 2007-2010: Department of Neurology, Second Affiliated Hospital of Soochow University.
2. 2009-2010: Doing Research into the regulation of dynein and autophagy in Zhou Jia wei’ Lab.(Development and Degeneration of Basal Ganglia), State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
3. 2010-: Stroke Unit Ward, Department of Neurology, Second Affiliated Hospital of Soochow University.
Basic and clinical research in stroke；Clinical research in neurointervention； Basic and clinical research in Parkinson’s disease seven years ago（mainly autophagy and neurodegenerative diseases）
Peng H, Zhu F, Shi J, et al. Serum Soluble Corin Is Decreased in Stroke. Stroke. 2015,46(7):1758-63. (co-first author)
Chrissa Sioka, M.D., D.Sci, is currently a Scientific Associate at the Neurosurgical Research Institute of the University of Ioannina, Greece. She received her MD in 1998 from the University of Sofia Medical School in Boulgaria, and her D.Sci from the University of Ioannina Medical School, in Greece. She is board certified in Nuclear Medicine (Greece) and has completed a six month special volunteer fellowship at the PET unit of the National Institutes of Health in Bethesda, MD, USA. Her research is focusing on molecular imaging techniques using SPECT and PET.
Imaging of brain tumors with nuclear medicine techniques; Body composition and bone mineral density in patients with multiple sclerosis; Imaging of paraneoplastic neurological syndromes
Dr. Michael J. Strong recently graduated from the MD/PhD program at Tulane University School of Medicine in New Orleans. He will be starting residency training in neurological surgery at the University of Michigan in Ann Arbor. His dissertation project utilized next generation sequencing and bioinformatics to investigate oncogenic pathogens. He has authored 30+ peer-reviewed publications. He has received numerous awards including the Alpha Omega Alpha Student Research Fellowship, the Campagna Scholarship in Neurological Surgery, the American Association of Neurological Surgeons Young Neurosurgeons Committee Mission Fellowship, and the National Institutes of Health National Research Service Award F30 Predoctoral Fellowship.
Transcriptomics in the study of pathogens and human malignancies; Human cytomegalovirus in the promotion of glioblastoma multiforme pathogenesis
Dr. Kyoungho Suk is currently a professor of Department of Pharmacology, Kyungpook National University (KNU) School of Medicine (Daegu, Korea), and the director of Brain Science & Engineering Institute of KNU. He obtained his Ph.D. in Immunology at University of California at Davis in 1994, and M.S. degree in Immunology at Cornell University in 1991. He graduated from KNU with the genetic engineering major in 1989. Dr. Suk received his postdoctoral training in the division of Rheumatology, Yale University School of Medicine, and he has been a visiting professor at Harvard Medical School between 2008 and 2009, during which he participated in large-scale experiments and systems biology approaches toward understanding of disease networks and pathways. Dr. Suk is the author of more than 200 papers published in peer-reviewed journals and holds patents on various therapeutic targets and lead compounds that could be used for the diagnosis or therapy of neuroinflammatory and neurodegenerative diseases.
For the past several years, Dr. Suk’s research focused on brain glial cells and neuroinflammation. Non-neuronal glial cells produce specific neurotransmitters and proteins under various physiological and pathological conditions to influence the survival and functions of neighboring neurons and glia in the central nervous system (CNS). Dr. Suk’s lab is interested in these proteins secreted from glial cells. A long-term goal of the lab is to identify and functionally characterize glial secretory proteins with respect to brain health and disease. Lipocalin-2, prostaglandin D2 synthase, and pentraxin-3 are a few examples of glial secretory proteins that the lab has been studying for several years. Dr. Suk’s findings based on in vitro and in vivo experiments as well as the analyses of clinical samples led to the discovery of potential biomarkers and drug targets for the acute CNS injuries and chronic disorders such as Alzheimer’s disease, vascular dementia, Parkinson’s disease, multiple sclerosis, and pathological pain. On-going works in the lab are now focused on the potential role of glial secretions in regulating the CNS functions from the physiological perspective. Glia-oriented omics approaches and large-scale experiments are also being employed to better understand a big picture of neuroinflammation and to uncover new drug targets for the devastating diseases in the CNS.
Glia; Neuroinflammation; Neurodegeneration; Functional genomics and proteomics based on large-scale experiments; Neuron-glia interaction via optogenetic control of glia
1. Lipocalin-2 as a therapeutic target for brain injury: An astrocentric perspective. Prog Neurobiol. 2016 Sep;144:158-72.
2. A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation. Nat Chem Biol. 2014 Dec;10(12):1055-60.
3. RNAi-based functional selection identifies multiple cell migration regulators dependent on PI3K/PTEN/AKT pathway. Nat Commun. 2014 Oct 28;5:5217.
Prof. Hua Su received different levels of trainings at the Nanjing Medical University, Xi’an Jiaotong University and Beijing medical University. She joined the faculty at University of California, San Francisco in 1996. Currently, she is a Professor and the Associate Director for Basic Science Research at the Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care. She is an experienced vascular biologist. Her long-term research interest is to develop therapeutic strategies that can improve outcomes in patients with cerebral vascular diseases.
Ischemic stroke; Brain arteriovenous malformation; Cerebrovascular malformation
Prof. Hua Su developed the first mouse brain arterovenous malformation (AVM) models, identified novel mechanisms that are responsible for brain AVM formation and progression.
Dr. Li Su is a principle investigator and Senior Research Fellow in Department of Psychiatry, the School of Clinical Medicine, University of Cambridge and an affiliated member of the EPSRC Centre for Mathematical Imaging in Healthcare. He is also a visiting professor and the co-founding director for the China-UK centre for cognition and ageing research in Southwest University in China. His main research interest is applying multimodal imaging and computational psychiatry approaches to dementia and other psychiatric conditions. Dr Li Su’s current research is supported by research grants from Addenbrooke’s Charitable Trust and the Lewy Body Society as well as a prestigious senior fellowship from Alzheimer’s Research UK.
Neuroimaging; computational modelling; dementia with Lewy bodies and other types of dementia
Dr. Li Su has published nearly 50 peer-review papers in international journals including Brain, Alzheimer’s and Dementia, Neuroimage, Human Brain Mapping, PloS computational biology, Journal of American Statistical Association and British journal of psychiatry. He acts as reviewer for several international journals and funding bodies such as MRC. He is an associate editor for Journal of Alzheimer’s Disease and member of editorial broad for several other journals. In 2015, he has been given the International College of Geriatric Psychoneuropharmacology Junior Investigator Award.
Academic - Research Appointments
1. Scientific Collaborator - Lecturer, Department of Anatomy, School of Medicine, European University Cyprus (Head: Prof Elizabeth Johnson) from academic year 2015-2016 until present; 2. Scientific Collaborator – Researcher, Neurosurgical Institute, University of Ioannina (Head: Prof. Athanasios Kyritsis) from 2011 until present. 3. Remote Research Collaborator, Witter-Group, Kavli Institute for Systems Neuroscience and Centre for Neural Computation, NTNU, Trondheim, Norway (Head: Prof. Menno Witter) from 2014 until present.
1. Consultant in Neuromuscular Diseases Unit, Department of Neurology, University Hospital of Ioannina (May 2015 – Present); 2. Medical Director in Military Health Care Center of Ioannina (August 2014 – Present) – Military Doctor, Neurologist, Captain of the Greek Army.
Anatomy and histology; Pathology; Physiology
Dr. Jun Tan received his Bachelors of Medicine in the Third Military Medical University, Chongqing, China in 1983. He earned his Masters of Science in human genetics at Fudan University in 1989. Three years later, he completed his Doctoral Degree in Biological Medicine. He completed postdoctoral studies in 1996 at the Department of Human Genetics/Microbiology & Immunology at the University of Michigan, Ann Arbor. In 1998 he became Assistant Professor of Psychiatry & Behavioral Medicine at USF Health - Morsani College of Medicine and was promoted to Associate Professor in 2004 and Professor/Endowed Chair in 2007. Over the past 20 years, Dr. Tan has authored more than 150 original scientific papers in prestigious national and international journals such as Science, Nature Neuroscience, Nature Medicine, Nature Commutations, EMBO J. He is the recipient of multiple grants/merit awards from the National Institute of Health, Veterans Administration and other peer reviewed funding sources totaling more than $15 million. Dr. Tan’s philosophy is that everyone on his team has a strength and that the best way to lead is to find a way to utilize those strengths together in building a concerted effort toward success.
Neurodegenerative disease; HIV-associated Dementia; Multiple sclerosis；HIV-associated Dementia; Alzheimer's Disease; Parkinson's Disease; Amyotrophic lateral sclerosis; Pick's Disease; Autoimmune disorders
Over the past 20 years, Dr. Tan has authored more than 150 original scientific papers in prestigious national and international journals such as Science, Nature Neuroscience, Nature Medicine, Nature Commutations, EMBO J.
Prof. Van den Noort received his MA-degree in Social Psychology (2000) and his MA-degree in Neuropsychology (2001) from the Radboud University Nijmegen (Nijmegen, the Netherlands) and his PhD-degree in Cognitive Neuroscience (2007) from the University of Bergen (Bergen, Norway). He is regular professor at Kyung Hee University (Seoul, South Korea) and he is visiting professor at the Free University of Brussels (Brussels, Belgium). In addition, he has worked as a guest-researcher (on a Harvard visiting scholar program) at Harvard University (Graduate School of Education, Cambridge, MA, USA).
Schizophrenia; Depression; Sleep disorders; Bilingualism; Theoretical Physics; fMRI; TMS
1. The development of a human (un)conscious brain information processing theory in which physics and neuroscience can be unified.
2.Professor Van den Noort is one of the leading Discussants of the possibilities and risks of brain stimulation. [see also Science: Science. 2014 Dec 12;346(6215):1307. doi: 10.1126/science.346.6215.1307-a]
1. 2016-present Professor, Department of Neurology, Xuanwu Hospital, Capital Medical University
2. 2012-2016 Vice president, The Sanming First Affiliated Hospital of Fujian Medical University
3. 2010-present Director, Department of Neurology, The Sanming First Affiliated Hospital of Fujian Medical University
4. 2008-present Associate Professor, Department of Neurology, Fujian Medical University
1. 1991-1996 MD degree, Department of Clinical Medicine, Gannan Medical College
2. 1999-2002 MS degree, Department of Neurology, Fujian Medical University
3. 2002-2003 Post-doctoral Fellow, Department of Medicine, Cancer Biology Division. Harvard, Institutes of Medicine, Harvard Medical School.(Boston, USA)
4. 2003-2006 Post-doctoral Fellow, Department of Medicine, Columbia University, Medical Center (New York, USA)
5. 2008-2011 PhD degree, Department of Neurology, Capital Medical University (Beijing, China)
Neurodegenerative; Neuroimmunological disorders
1. A study on the mechanisms, prediction and intervention, The First Prize for Beijing Science and Technology, 2015;
2. A study on the clinical features and genetics of multiple sclerosis, The Third Prize for the Jiangxi Science and Technology, 2011;
3. Multiple regulatory roles of Immune-related GTPase IRGM1 in multiple sclerosis and cerebral vascular diseases. The First Prize for Sanming Science and Technology.
Dr. Jia-Wei Wang has got his Bachelor degree from the Harbin Medical University, China in 1991,and for his Masters and Doctoral degree study in 2002 from Beijing Friendship Hospital, Capital Medical University. He did his postdoctoral work at John Hopkins university in 2008. Now is the director of department of neurology and medical research center, the Beijing Tongren Hospital, Capital Medical University.
Anti autoimmune encephalitis; Neuromyelitis optica; Cerebrovascular disease; Multiple sclerosis; Myasthenia gravis; Dizziness; Headache
Till now, Dr. Jia-Wei Wang has published several high-quality articles about his research areas.
Dr. Wang obtained his Ph.D. in Pharmaceutical Sciences with Distinction from the University of British Columbia in Vancouver in 1989. He is internationally recognized for his original contributions to the fields of CNS disorders-linked proteolytic enzymes, neuroproteomics and disease biomarker discovery. He joined Parke-Davis Pharmaceutical Research (Ann Arbor, MI) in 1991, and following the company's merger with Pfizer Inc. (2000), he became Group Leader of CNS Therapeutics/CNS new targets team. He also co-chaired the Far East Scientific Opportunity Team. In 2002, he became Associate Professor of Psychiatry at the University of Florida (Gainesville, FL), Associate Director of the Center for Traumatic Brain Injury Studies and Director of the Center of Neuroproteomics and Biomarkers Research. In 2002, he co-founded Banyan Biomarkers Inc. (Alachua, Florida). In 2007, he transitioned to Banyan as full-time Chief Scientific Officer and the Center Director of the Center of Innovative Research. In 2011, he rejoined the University of Florida McKnight Brain Institute as Executive Director of the Center of Neuroproteomics and Biomarkers Research / Chief - Translational Research & Associate Professor of Psychiatry and Neuroscience and to rededicate himself to basic and translational research. He is also Chair Professor of the Taipei Medical University. Dr. Wang published more than 200 peer-reviewed papers, reviews and book chapters and co-authored eight US patents. He co-edited four books on proteases, neuroproteomics and biomarkers for CNS disorders. He also serves on five international journal’s Editorial Board. Dr. Wang was Past President and is current Council member of the National Neurotrauma Society (USA).
Neuro-Proteomics; CNS Injury; Neurodegeneration; Substance abuse research; Post-translational modification (Protease / Protein Kinase) research; Biomarkers; Diagnostics and Therapeutic development
Dr. Lijun Wang currently is the Director of Genetics at BloodCenter of Wisconsin. Dr. Wang previously was an Assistant Professor of Human Genetics at Emory University. Dr. Wang’s clinical and research Interests include molecular diagnosis of genetic disorders, clinical and research applications of next-generation sequencing, and pathogenesis of neurodegenerative disorders (e.g., Amyotrophic Lateral Sclerosis). In particular, Dr. Wang is interested in Hematogenetics and Neurogenetics.
Yan-Jiang Wang is the director of Department of Neurology in Daping Hospital, Third Military Medical University, China. He is also the vice chair of Academy of Cognitive Disorder of China and director of Vas-Cog Asia. He completed his MD training at Third Military Medical University in China, and PhD training at Flinders University in Australia. He has focused his research and clinical practice on identification of risk factors of Alzheimer’s disease in clinical settings, and development of novel therapies for Alzheimer’s disease. He has published over 70 papers in referred journals including Nature Reviews Neurology, PNAS, Molecular Psychiatry, Acta Neuropathologica and Neurology.
Neurology; Stroke and dementia; Alzheimer's disease
Dr. Sara Xapelli is an investigator at Instituto de Medicina Molecular. For her PhD Sara was involved in the research of receptor-mediated mechanisms of neuroprotection and anticonvulsant properties of neuropeptide Y. During her postdoctoral studies, Sara has been interested in the role of endocannabinoids in neurogenesis and oligodendrogenesis and their relevance in both the intact and damaged brain. Currently, she is the leader investigator of several research projects aiming at finding modulators of neurogenesis and oligodendrogenesis derived from neural stem cells.
Neural stem cells; Neurodegenerative disorders; Neuroprotection; Neurogenesis; Oligodendrogenesis
Till now, Dr. Sara Xapelli has published 25 high-quality articles about his research areas.
Dr. Xia is a Researcher Associate Professor of State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University. He received his Ph.D. degree in cognitive neuroscience from Beijing Normal University. Dr. Xia’s research focuses on the computing methods of human brain connectomics big data and its application in neuropsychiatric disorders, as well as the development of analysis and visualization software for human brain connectomics.He has published over35SCI papers in Cerebral Cortex and other important journals in recent five years and had a total citation count of 1952 (Google Scholar).
The computing method of human brain connectomics; The application of human brain connectomics in neuropsychiatric disorders; The development of analysis and visualization software for human brain connectomics
2005-2008 Resident in Neurology, Beijing Friendship Hospital, Capital Medical University
2008-2010 Fellow in Neuroimmunology, Beijing Friendship Hospital, Capital Medical University
2010-2012 Attending physician, Department of Neurology, Beijing Friendship Hospital, Capital Medical University
2012-2014 Associate Professor, Department of Neurology, Beijing Friendship Hospital, Capital Medical University
2013-2014 Visiting Scholar, Department of Neurology, The George Washington University
2014-present Scientist, Department of Neurology, The George Washington University
Myasthenia Gravis; Genetic study; Translocation medicine
1. Identify the variations in glucocorticoid receptor (GR) gene which are associated with the response to glucocorticoid in patients with myasthenia gravis (MG).
2. Identify the increase of GRβ in peripheral blood mononuclear cell (PBMC) is associated with bad response to glucocorticoid in patients with MG.
3. Identify the predisposing genes in HLA region of patients with MG.
1. Transplant and Immunology Fellow (Director In Training), University of Chicago Medicine. 2. August 2016–Present (5 months) Greater Chicago Area, Research Assistant Professor, Loyola University Chicago. 3. December 2013–July 2016 (2 years 8 months) Research Assoicate, Hines VA Hospital/Loyola. 4. June 2008–2013 (5 years) Postdoctoral fellow, Forensic Doctor, West China University of Medical Sciences. 5. July 1996–May 2001 (4 years 11 months) Chengdu, Sichuan, China.
Neuroscience, Immunology, Hematology, Histocompatability
1. MDA Development Award 2011-2014 (Role: PI), Muscular Dystrophy Association, July 2011.
2. LRF New Investigator Award (Role: PI), Leukemia Research Foundation, July 2014.
3. PepsiCo research competition finalist, November 2011.
4. Young Investigator’s Educational Enhancement (YIEE)” travel award, American Society of Neurochemistry, 2012.
5. Arthur J. Schmitt Dissertation Fellowship Award, Loyola University Chicago, 2007.
6. Graduate Travel Award, Society for Neuroscience, 2007.
7. Winner of Graduate Student Symposium, Chicago Chapter Society for Neuroscience, 2007.
8. 3rd Place, St. Albert’s Day Research Presentation, Loyola University Chicago 2007.
9. Outstanding Graduate of University, West China University of Medical Sciences, June 1996.
10. Outstanding Student Fellowship of University, West China University of Medical Sciences, 1993-1995.
11. Travel Award, Chicago Association for Research and Education in Science 2013.
12. 3rd place, Research Poster Competition, Hines VA Hospital, 2011.
13. Creator of gene ID cardFebruary,2001.
14. China Medical Board-sponsored Young scholar, China Medical Board, 2000.
15. Outstanding Leadership and Dedication as the President of the Chinese Student and Scholar Association, Consulate General of the P. R. China in Chicago, 2004.
Autoimmune diseases; T cell function and mechanism; Antibody-based immune therapy
1. Scientist Development Grant, AHA-0830072N;
2. 2008-2011 American Heart Association;
3. MS4a4B as a novel modulator for the cell cycle regulation in T cells;
4. Junior Faculty Travel Award, AAI, 2010;
5. Travel Award, AAI, 2008;
6. 1998 Cora Verhagen Prize, ARVO;
7. 1998 NIH Research Excellence Award;
8. 1999 Pfizer-Showell Travel Award (FASEB), the first recipient of the this Award;
9. 1998 ARVO Travel Award, ARVO;
10. 1998 Research Excellence Award, NIH, 2008.
Guo-Yuan Yang, MD, PhD, Kuan Cheng Wong endowed Professor of Shanghai Jiao Tong University, the Fellow at the American Institute for Medical and Biological Engineering (AIMBE). Recently, Dr. Yang has developed angiogenesis and microvessel dysplasia model in rodent brain for cerebrovascular research. He is also working on exploring new treatments for stroke and brain tumors by taking advantages of neuroimaging, neural rehabilitation, biomaterials, and medical device. He has published more than 240 scientific papers with the total impact factor (IF) more than 800, which were cited more than 10000 times.
1. the mechanisms of cerebrovascular diseases in both basic and clinical fields; 2. applications of synchrotron radiation in studies on neurological diseases; 3. applications of biological materials in neurological diseases
Dr. Jun Yang received his MD/MS from Lanzhou University in 1982/1989. Subsequently, he was working as an associate professor in the Department of Neurosurgeon, the Second Teaching Hospital of Lanzhou University and Zhong-Shan Hospital of Xiamen University. He pursued his research works involving in a variety of clinical and basic researches in Georgetown University Medical Center, Loyola University Medical Center, and Cleveland Clinic Lerner College of Medicine. He is currently a research staff/clinical assistant professor in the Departments Of Neurosurgery/BME in Cleveland Clinic Lerner College of Medicine and Case Western Reserve University, Cleveland, Ohio, USA.
Traumatic head injury (TBI); Stroke (cerebral ischemic model and treatment); gene therapy for epilepsy; Parkinson’s disease; ALS; cancer research, brain tumor and brain abscess research; NPH; hydrocephalus; CSF biomarker; spinal cord injury (SCI); and antioxidant etc.
Till now, Dr. Yang has published more than 38 high-quality articles about his research areas. He is a reviewer of eight different Journals. He is a member of five different scientific societies. He received four awards in his research works.
Prof. Yang Li is currently the Vice Chairman of the Department of Neurology in Tianjin Medical University General Hospital in China. She received her MD degree in 1992 from Tianjin Medical University, Nankai University and PhD degree in 2002 from the Tianjin Medical University. From 2007 to 2008, she worked as a Post-doctoral Fellow in University of Oxford in United Kingdom. She has been engaged in the clinical, teaching and scientific research of neuroimmunological diseases from 1992 till now.
Myelitis; Encephalitis; Myasthenia gravis; Demyelinating disease and the autoimmune encephalopathy
1. Shi Q, Yang L, and Shi FD. 2011. “Pathology of Multiple Sclerosis”. In Demyelinated Disease in Nervous System. People’s Health Publishing House.
2. Zhang D, Yang L. 2011. “Guillain-Barre Syndrome”. Neurosurgical Intensive Care. People’s Health Publishing House.
3.Zhang D, Yang L. 2013. “Neuromyelitis Optica”. Neurology. People’s Health Publishing House.
Zang Yu-Feng, MD, is a professor with the Center for Cognition and Brain Disorders. He got his Bachelor degree of medicine in Hebei Medical College in 1984, Master degree of neurosurgery in Tianjin Medical College in 1991, and Doctor degree of psychiatry in Peking University in 2002. Before he started neuroimaging research, he had served as a neurosurgeon for 14 years. Zang was listed as Most Cited Chinese Researchers by Elsevier in 2014, 2015, and 2016 (in Neuroscience).
Resting-state fMRI (RS-fMRI) analysis and application to cognitive neuroscience and brain disorders
Xinghu Zhang, Professor of Neurology， is a director of Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University. He is vice chief member of Immunology Branch of Chinese Stroke Association, vice director of Neuroimmunology Group of Neurology Branch of Beijing Medical Society,vice chief member of Neuroimmunology Specialty Committee of Beijing Neurology Association,member of Neuroimmunology Group of Neurology Branch of Chinese Medical Association,member of Neuroimmunology Branch of Chinese Immunology Society,member of Neuroimmunological Disease Specialty Committee of Neurology Doctor Branch of Chinese Doctor Society, member of Beijing Immunology Society,vice director of Neurology Specialty of Capital Medical University, member of Editorial Broad of Chinese Neuroimmunology and Neurology Journal.
Papilledema; Horner syndrome; Behcet syndrome; Neuroinflammation; Inflammation mediators; Myelitis; Encephalitis; Papilledema; Horner syndrome; Behcet syndrome
Dr. Rui Zhao is currently associate professor of Changhai Hospital affiliated to Second Military Medical University. He graduated from SMMU in 2001. Subsequently, he got MD and PhD of Neurosurgery in SMMU and worked in Changhai hospital. His clinic practice and research mainly focused on Cerebrovascualr Diseases.
Cerebral and spinal vascular Diseases; such as intracranial aneurysm; AVM; DAVF; Ischemic CVD; Moyamoya disease; Interventional Neuroradiology; Regenerational Medicine
1.Li Z, Fang XG, Yang P, Huang Q, Liang C, Zhao R , Liu JM. Endothelial Progenitor Cells Contribute to Neointima Formation in Rabbit Elastase-induced Aneurysm after Flow-diverter Treatment. CNS Neurosci Ther. 2013 May;19(5):352-7.
2.Huai W, Zhao R, Song H, Zhao J, Zhang L, Zhang L, Gao C, Han L, Zhao W*. Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription.Nat Commun. 2014 Aug 20;5:4738. doi: 10.1038/ncomms5738.
3.Liang C, Feng H, Deng BQ, Li ZF, Huang QH, Zhao W, Zhao WY, Yang PF, Xu Y, Zhao R, Liu JM.Decreased levels and function of circulating endothelial progenitor cells in unruptured intracranial saccular aneurysm patients. Neurol Sci. 2014 Jan;35(1):23-8.
4.Song H, Deng B, Zou C, Huai W, Zhao R, Zhao W.GSK3β negatively regulates LPS-induced osteopontin expression via inhibiting its transcription. Scand J Immunol. 2015 Mar;81(3):186-91.